Keros Therapeutics, Inc. (KROS)

USD 17.13

(-4.83%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 370.02 Million 306.78 Million 255.25 Million 269.44 Million 10.95 Million 27.41 Million
Total Current Assets 347.29 Million 285.76 Million 251.44 Million 267.72 Million 8.92 Million 25.53 Million
Cash And Short Term Investments 331.14 Million 279.04 Million 230.04 Million 265.87 Million 7.02 Million 23.25 Million
Cash and Cash Equivalents 331.14 Million 279.04 Million 230.04 Million 265.87 Million 7.02 Million 23.25 Million
Short Term Investments - - - - - -
Net Receivables 1.09 Million 841 Thousand 18 Million 216 Thousand 922 Thousand -
Inventory 14.05 Million -841 Thousand 3.05 Million 1.47 Million 759 Thousand -
Other Current Assets 1 Million 6.71 Million 340 Thousand 160 Thousand 226 Thousand 84 Thousand
Total Non-Current Assets 22.73 Million 21.01 Million 3.81 Million 1.71 Million 2.02 Million 1.88 Million
Net PPE 19.46 Million 17.56 Million 2.4 Million 1.6 Million 1.91 Million 1.38 Million
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments 1.21 Million 1.32 Million 1.32 Million 115 Thousand 115 Thousand 501 Thousand
Tax Assets - - - - - -
Other Non Current Assets 2.05 Million 2.11 Million 82 Thousand - - -
Other Assets - - - - - -
Total Liabilities 37.81 Million 29.35 Million 12.07 Million 7.72 Million 5.5 Million 14.65 Million
Total Current Liabilities 24.37 Million 16.54 Million 11.84 Million 7.18 Million 4.48 Million 11.46 Million
Account Payables 5.45 Million 3.33 Million 3.64 Million 2.14 Million 2.08 Million 501 Thousand
Tax Payables - 50 Thousand 110 Thousand 185 Thousand 43 Thousand 284 Thousand
Short Term Debt 1 Million 455 Thousand 862 Thousand 423 Thousand 376 Thousand 166 Thousand
Deferred Revenue 17.25 Million - 7.13 Million 4.39 Million 1.91 Million 10 Million
Other Current Liabilities 665 Thousand 12.75 Million 204 Thousand 218 Thousand 107 Thousand 802 Thousand
Total Non Current Liabilities 13.43 Million 12.81 Million 231 Thousand 538 Thousand 1.01 Million 3.18 Million
Long-Term Debt 13.43 Million 12.81 Million 231 Thousand 476 Thousand 899 Thousand 622 Thousand
Deferred Revenue Non Current - - - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities - - - 62 Thousand 119 Thousand 2.56 Million
Other Liabilities - - - - - -
Total Equity 332.21 Million 277.42 Million 243.17 Million 261.72 Million 5.45 Million 12.75 Million
Stock Holders Equity 332.21 Million 277.42 Million 243.17 Million 261.72 Million 5.45 Million 12.75 Million
Common Stock 3000.00 2000.00 2000.00 2000.00 2000.00 1000.00
Retained Earnings -381.42 Million -228.43 Million -123.75 Million -65.01 Million -19.65 Million -7.31 Million
Accumulated other comprehensive income - - - -269.44 Million -19.94 Million -246 Thousand
Common Stock Equity 332.21 Million 277.42 Million 243.17 Million 261.72 Million 5.45 Million 12.75 Million
Capital Lease Obligation 14.44 Million 13.26 Million 1.09 Million 899 Thousand 1.27 Million 788 Thousand
Total Investments 1.21 Million 1.32 Million 1.32 Million 115 Thousand 115 Thousand 501 Thousand
Total Debt 14.44 Million 13.26 Million 1.09 Million 899 Thousand 1.27 Million 788 Thousand
Net Debt -316.7 Million -265.78 Million -228.94 Million -264.97 Million -5.74 Million -22.47 Million

Balance Sheet Charts